Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-04
DOI
10.3389/fmed.2021.653634
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care
- (2021) Silvio Borrelli et al. Nutrients
- Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain
- (2021) Antonio Olry de Labry Lima et al. Clinical Kidney Journal
- Sodium zirconium cyclosilicate use in solid organ transplant recipients and its effect on potassium and immunosuppression
- (2020) Ryan J. Winstead et al. CLINICAL TRANSPLANTATION
- Cost‐analysis of persistent hyperkalaemia in non‐dialysis chronic kidney disease patients under nephrology care in Italy
- (2020) Michele Provenzano et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Let Them Eat Healthy: Can Emerging Potassium Binders Help Overcome Dietary Potassium Restrictions in Chronic Kidney Disease?
- (2020) Elizabeth J. Sussman et al. JOURNAL OF RENAL NUTRITION
- Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double‐blind, Placebo‐controlled Study (ENERGIZE)
- (2020) W. Frank Peacock et al. ACADEMIC EMERGENCY MEDICINE
- Postdischarge Health Care Costs and Readmission in Patients With Hyperkalemia-Related Hospitalizations
- (2020) Keith A. Betts et al. Kidney International Reports
- A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia
- (2020) Naoki Kashihara et al. Clinical and Experimental Nephrology
- Novel approaches to management of hyperkalaemia in kidney transplantation
- (2020) John Rizk et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Clinical Management of Hyperkalemia
- (2020) Biff F. Palmer et al. MAYO CLINIC PROCEEDINGS
- Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study
- (2020) Edouard L. Fu et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
- (2019) Bruce S. Spinowitz et al. Clinical Journal of the American Society of Nephrology
- Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology
- (2019) Stefano Bianchi et al. JOURNAL OF NEPHROLOGY
- A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
- (2019) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Safety, effectiveness and tolerability of patiromer in kidney transplant recipients
- (2019) Mary Ann Lim et al. TRANSPLANTATION
- Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider
- (2019) Aleix Cases et al. Nutrients
- Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
- (2019) J. Ariana Noel et al. JAMA Internal Medicine
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Rajiv Agarwal et al. LANCET
- Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study
- (2019) Paola Laureati et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Patiromer for Treatment of Hyperkalemia in the Emergency Department: A Pilot Study
- (2019) Zubaid Rafique et al. ACADEMIC EMERGENCY MEDICINE
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2019) Catherine M. Clase et al. KIDNEY INTERNATIONAL
- Risk of hyperkalemia from renin–angiotensin–aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population
- (2019) James B Wetmore et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study
- (2019) Simon D Roger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis
- (2018) Csaba P Kovesdy et al. EUROPEAN HEART JOURNAL
- The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia
- (2018) Bertram Pitt et al. Expert Opinion On Drug Safety
- Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice
- (2018) Luca De Nicola et al. JOURNAL OF NEPHROLOGY
- Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function
- (2018) Adamasco Cupisti et al. Nutrients
- Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
- (2018) Bryan Williams et al. Lancet Diabetes & Endocrinology
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. EUROPEAN HEART JOURNAL
- Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors
- (2018) Robert A. Kloner et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Calcium-Polystyrene Sulfonate Decreases Inter-Dialytic Hyperkalemia in Patients Undergoing Maintenance Hemodialysis: A Prospective, Randomized, Crossover Study
- (2018) Jing Wang et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia
- (2018) Sheridan M. Hoy DRUGS
- Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
- (2018) Robert M. Carey et al. HYPERTENSION
- Safety and efficacy of patiromer use with tacrolimus in kidney transplant recipients
- (2018) Rungwasee Rattanavich et al. TRANSPLANT INTERNATIONAL
- Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care
- (2018) Michele Provenzano et al. Journal of Clinical Medicine
- A meta-analysis of add-on use of spironolactone in patients with resistant hypertension
- (2017) Di Zhao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers
- (2017) Lawrence J. Lesko et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics
- (2017) Matthew R. Weir et al. JOURNAL OF HYPERTENSION
- Nutritional Management of Chronic Kidney Disease
- (2017) Kamyar Kalantar-Zadeh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients
- (2017) Mi-Yeon Yu et al. PLoS One
- Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
- (2017) Morten Schmidt et al. BMJ-British Medical Journal
- Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
- (2017) Morten Schmidt et al. BMJ-British Medical Journal
- Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
- (2017) Ghassan Bandak et al. Journal of the American Heart Association
- Physiology and pathophysiology of potassium homeostasis
- (2016) Biff F. Palmer et al. ADVANCES IN PHYSIOLOGY EDUCATION
- Effect of Patiromer on Urinary Ion Excretion in Healthy Adults
- (2016) David A. Bushinsky et al. Clinical Journal of the American Society of Nephrology
- Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia
- (2016) Lingyun Li et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors
- (2016) Matthew R. Weir et al. KIDNEY INTERNATIONAL
- Updates in hyperkalemia: Outcomes and therapeutic strategies
- (2016) Csaba P Kovesdy REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients
- (2016) Jung-Im Shin et al. TRANSPLANTATION
- Potassium homeostasis and dyskalemias: the respective roles of renal, extrarenal, and gut sensors in potassium handling
- (2016) Murray Epstein et al. Kidney International Supplements
- Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease
- (2015) Georges N. Nakhoul et al. AMERICAN JOURNAL OF NEPHROLOGY
- Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD
- (2015) L. Lepage et al. Clinical Journal of the American Society of Nephrology
- Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial
- (2015) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient
- (2015) Stephen R. Ash et al. KIDNEY INTERNATIONAL
- New Agents for Hyperkalemia
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated View of Potassium Homeostasis
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
- (2015) Matthew R. Weir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium Zirconium Cyclosilicate in Hyperkalemia
- (2015) David K. Packham et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Colon as the Potassium Target: Entering the Colonic Age of Hyperkalemia Treatment?
- (2015) Daniel Batlle et al. EBioMedicine
- Regulation of Potassium Homeostasis
- (2014) B. F. Palmer Clinical Journal of the American Society of Nephrology
- Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia
- (2014) Mikhail Kosiborod et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of hyperkalaemia in chronic kidney disease
- (2014) Csaba P. Kovesdy Nature Reviews Nephrology
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?
- (2013) David C. Wheeler et al. KIDNEY INTERNATIONAL
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Prescription of Oral Sodium Polystyrene Sulfonate With Sorbitol in an Inpatient Setting With Colonic Necrosis: A Retrospective Cohort Study
- (2012) Maura A. Watson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
- (2011) B. Pitt et al. EUROPEAN HEART JOURNAL
- The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
- (2009) Lisa M. Einhorn et al. ARCHIVES OF INTERNAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search